Get the Stockscreener App
5.22
1.16%
0.06
After Hours:
5.22
Olema Pharmaceuticals Inc Stock (OLMA) Latest News
OLMA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Upward Trajectory: Olema Pharmaceuticals Inc (OLMA) Posts a Slidee, Closing at 5.69 - The Dwinnex
The Significance of Moving Averages in Olema Pharmaceuticals Inc Inc. (OLMA) Price Performance - The InvestChronicle
There is no way Olema Pharmaceuticals Inc (OLMA) can keep these numbers up - SETE News
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
OLMAOlema Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Olema Pharma's Strategic Talent Acquisition: $1.7M in Equity Grants Signals Growth Push - StockTitan
Olema Pharmaceuticals Inc (OLMA) Becoming More Attractive for Investors - Knox Daily
Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News
Financial Metrics Exploration: Understanding Olema Pharmaceuticals Inc (OLMA) Through Ratios - The Dwinnex
Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Exclusive Access: Olema Pharmaceuticals Reveals Latest Oncology Progress at Two Elite Healthcare Forums - StockTitan
HR Positive/ HER2 Negative Breast Cancer Pipeline 2024: MOA - openPR
How To Trade (OLMA) - Stock Traders Daily
JPMorgan Chase & Co. Buys 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Purchases 157,171 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Holdings Increased by Hennion & Walsh Asset Management Inc. - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $27.00 Consensus Target Price from Brokerages - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Form 424B5 Olema Pharmaceuticals, - StreetInsider.com
Barclays PLC Purchases 48,614 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Bain Capital Life Sciences Investors, LLC Acquires Significant S - GuruFocus.com
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Major Shareholder Acquires $1,728,000.00 in Stock - MarketBeat
Bain Capital Life Sciences buys $1.7m in Olema Pharmaceuticals stock - Investing.com Nigeria
Olema Pharmaceuticals announces equity security exchange By Investing.com - Investing.com Australia
Olema Pharmaceuticals announces equity security exchange - Investing.com India
Olema Pharmaceuticals stock hits 52-week low at $5.02 - Investing.com India
Olema Pharmaceuticals stock hits 52-week low at $5.02 By Investing.com - Investing.com South Africa
(OLMA) Investment Report - Stock Traders Daily
Olema Pharmaceuticals Awards New Employee Stock Options for Cancer Drug Development Team - StockTitan
Olema Pharmaceuticals stock hits 52-week low at $5.55 By Investing.com - Investing.com Australia
Olema Pharmaceuticals stock hits 52-week low at $5.55 - Investing.com India
Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Olema Pharmaceuticals CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Decreases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Geode Capital Management LLC Sells 125,170 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Barclays PLC Acquires 48,614 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateForm 8-K - Marketscreener.com
Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion - MSN
State Street Corp Boosts Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of “Buy” by Brokerages - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of "Buy" by Brokerages - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 7,616 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Top 3 Health Care Stocks That May Explode In Q4 - Benzinga
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):